Masonic Cancer Center

A Comprehensive Cancer Center designated by the National Cancer Institute

Find a Clinical Trial

Quick Search (by title or disease)
  

Go to Advanced Search for more options.

Clinical Trials Help
Contact our Cancer Information Line nurse with your questions about open or upcoming clinical trials, second opinions, or patient referrals.
ccinfo@umn.edu • 612-624-2620 • 1-888-226-2376

  Sip Protocol

Masonic Cancer Research Center
ccinfo@umn.edu • 612-624-2620 • 1-888-226-2376

Back to Search Instructions

Protocol No. 2013CG010 Principal Investigator Moertel, Christopher
Phase Phase III
Age Group Both Scope National
Secondary Protocol No. ACNS0334
Title MT2013-08 - COG ACNS0334 - A Phase III Randomized Trial for the Treatment of Newly Diagnosed Supratentorial PNET and High Risk Medulloblastoma in Children < 36 months Old with Intensive Induction Chemotherapy with Methotrexate Followed by Consolidation with Stem Cell Rescue vs. the Same Therapy Without Methotrexate
Applicable Disease Sites Brain and Nervous System
Drugs Involved CARBOPLATIN (PARAPLATIN)
CISPLATIN (PLATINOL, CDDP)
CYCLOPHOSPHAMIDE (CYTOXAN, NEOSAR)
ETOPOSIDE (VP-16)
METHOTREXATE
THIOTEPA
VINCRISTINE (ONCOVIN)
Status Open
Participating Institutions Masonic Cancer Center
Treatment Type Treatment
Contact Tambra Dahlheimer Phone:612-626-2629
Email:tdahlheimer@umphysicians.umn.edu
  • ©2013 Regents of the University of Minnesota. All rights reserved.
  • The University of Minnesota is an equal opportunity educator and employer
  • Last modified on